Having options can lower vaccine hesitancy, finds research
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
1
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
1
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs—the way TB enters the body.
Apr 15, 2024
0
21
New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.
Apr 12, 2024
0
47
Health care providers and patients have traditionally thought that infections patients get while in the hospital are caused by superbugs they're exposed to while they're in a medical facility. Genetic data from the bacteria ...
Apr 11, 2024
1
74
A new study published today in the American Journal of Infection Control (AJIC) reports the infection prevention steps taken to control a months-long, multispecies outbreak of carbapenemase-producing Enterobacterales that ...
Apr 11, 2024
1
0
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
It's one of the most contagious viral diseases in the world—and outbreaks are popping up across the United States. More than 60 measles cases have been reported so far this year in 17 states, from Washington to Florida; ...
Apr 4, 2024
0
13
Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there's limited clinical experience. Nevertheless, successfully identifying ...
Apr 3, 2024
0
0
As we age, the immune system's efficacy weakens, leading to less effective defenses against new pathogens—such as the SARS-CoV-2 virus. How immunosenescence in older adults affects their immune response to COVID-19 mRNA ...
Apr 3, 2024
0
0
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective ...
Apr 2, 2024
0
27